So we are expanding beyond biliary tract cancer into metastatic head and neck squamous cell cancer?
Dr Google: The prognosis of patients with recurrent or metastatic head and neck squamous cell cancer is generally poor. The median survival in most series is 6 to 15 months depending on patient- and disease-related factors.
